Evolve Hypromellose 0.3%

Product Information

NUH approved in accordance with NICE TA297 for use by ophthalmology for treating vitreomacular traction in adults. Not to be used at SFH (patients would be referred to a speciallist centre). NUH: Approved by NHS England for specialist centre use only, in accordance with NICE HST11. NUH to refer patients to specialist centre (GOSH and Moorfields, Oxford University Hospitals, Manchester University Hospitals)

SFH advice only: Each dose unit contains 8 drops and can be re-capped and used within 24 hours of opening. Systane eye drops and Preservative Free eye drops: lubricant fordry eyes -see dry eye guidance below Acne Acne is a common skin condition that affects most people at some point. It causes spots, oily skin and sometimes skin that’s hot or painful to touch. Acne most commonly develops on the face. NUH neonatal guideline available, vial presentation (not syringe) to be supplied alongside Vissisure kit for administration.Approved in accordance with MHRAEarly Access to Medicines Scheme to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy (DMD) from the age of 10 years who are currently not taking glucocorticoids. EAMS number 46555/0001. NICE TA409:Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion

The Evolve system has been designed to combine the benefits of unit dose preservative free eye drops with the convenience of a standard eye drop bottle. Including brands such as Clinitas Hot Eye Compress, Meibopatch, MGDRx EyeBag, Optase Moist Heat Mask. No new patients to receive prescriptions in primary care. Patients already receiving Red Medicines in primary care should be handled on a case by case basis with the support of the Medicines Optimisation team. Do NOT use this product if you are allergic to any of the ingredients in this product (see ingredients tab for full list). Speak to your doctor or a Chemist 4 U pharmacist before using this product if you: NUH prescribing will be undertaken within the ophthalmology department and will be a two consultant decision.Secondary Careprescribing: Brand supplied will depend on availability. Evolve ® brand is a cost-effective option. Cross-linked Carboxymethylcellulose (CMC) 0.4% + Co-enzyme Q10 (CoQ10) 0.1% + Vitamin E 0.5% + Poloxamer 407 9%) Optive Fusion ® - Hyaluronate 0.1%, carmellose 0.5%, glycerol 0.9% (preserved and preservative free) Hypromellose 0.25% eye drops are not recommended for prescribing within Leeds Health Economy. The licenced 0.3% drops are available for a much lower cost. NUH only - Visual impairment in adults caused by macular oedema after branch retinal vein occlusion (BRVO) NICE TA409

Approved for use in accordance with NICE TA800 for treating wet age-realted macular degeneration in adults. Visual impairment due to macular oedema secondary to central retinal vein occlusion (CRVO) NICE TA305 NICE TA283: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusionPlease take care that the dropper doesn't touch your eye, your fingers, or any other surface. This could contaminate the drops left in the bottle.

For use only in patients with moderate to severe dry eye with corneal epithelial stains and on the recommendation of a specialist. These effects should wear off after a short time. If these effects persist or get worse stop using this product immediately and speak to your doctor or a Chemist 4 U pharmacist.Not commissioned( Clinical Commissioning Policy: 200401P) for treating patients over 12 years of age, with Leber’s Hereditary Optic Neuropathy (LHON). Evolve Hypromelloseis both preservative free and phosphate free, ideal for sensitive eyes and frequent users